yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q33395360-6CB16EEC-E646-44B2-AD31-E43059065F9D
Q33395360-6CB16EEC-E646-44B2-AD31-E43059065F9D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33395360-6CB16EEC-E646-44B2-AD31-E43059065F9D
Radioimmunotherapy with (131)I-rituximab for patients with relapsed/refractory B-cell non-Hodgkin's lymphoma (NHL).
P2860
Q33395360-6CB16EEC-E646-44B2-AD31-E43059065F9D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33395360-6CB16EEC-E646-44B2-AD31-E43059065F9D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
20a8862e4913eaf65d19399b887a69eba384ed10
P2860
Phase III study of R-CVP compared with cyclophosphamide, vincristine, and prednisone alone in patients with previously untreated advanced follicular lymphoma.